4th International Symposium on Urea Cycle Disorders: Catalyzing New Therapeutic Approaches
ABC News Story: April 26, 2012 - ABC News featured a story on a young man with ASA and chronically high blood pressure. Dr. Brendan Lee’s (Baylor College of Medicine) ASA and nitric oxide research led to a new approach to treat his condition. http://abcnews.go.com/Health/boy-toxic-buildup-breakthrough-treatment/story?id=16213994.
Washington Post: November 25, 2010 – Dr. Uta Lichter-Konecki diagnoses girl with UCD. http://www.washingtonpost.com/wp-dyn/content/article/2010/11/24/AR2010112406714.html
Good Morning America: May 7, 2006 - Mark Batshaw, M.D., Principle Investigator for the Urea Cycle Disorders Consortium and member of the NUCDF Medical Advisory Board, was interviewed by Good Morning America for a segment that aired May 7, 2006. The segment profiled the Rare Diseases Clinical Research Centers, sponsored by the National Institutes of Health. The segment focused on our Urea Cycle Disorders Consortium as an example of this pioneering NIH project.
Washington Post Featured Story: Saving a girl from her own body's poisons Read More >
UCDC Launches New Web Site en Español! Mira aqui!
Urea Cycle Disorders Consortium 2010 Summer Conference
2010 National Urea Cycle Disorders Foundation Annual Conference
Satellite Symposium to the 11th International Congress on Inborn Errors of Metabolism
2009 National Urea Cycle Disorders Foundation Annual Conference
20072007 National Urea Cycle Disorders Foundation Annual Conference
July 6-8, 2007
Grand Hyatt Hotel, Washington D.C.
For information: www.nucdf.org or contact: Cindy@nucdf.org
May 5, 2006 Press Release: NIH Launches Clinical Studies Nationwide to Investigate Rare Diseases
2006 NUCDF Annual Family Conference
2005 NUCDF Annual Family Conference
Society for Inherited Metabolic Disorders Annual 2005 Meeting
The Urea Cycle Disorders Consortium (UCDC) is a part of NIH Rare Diseases Clinical Research Network (RDCRN). Funding and/or programmatic support for this project has been provided by the National Institute of Child Health and Human Development (NICHD) and the NIH Office of Rare Diseases Research (ORDR). Read Disclaimer >